Detailed structural studies of PGA and its complexes should create a foundation for rational development of l-asparaginases with modulated relative activities vs. l-Asn or l-Gln25, which appears to be of major importance in developing improved anti-leukemia therapeutics. The gene discussed is ASPG; the disease is leukemia.